European Journal of Psychotraumatology (Jul 2022)

Anticipating PTSD in severe COVID survivors: the case for screen-and-treat

  • Talya Greene,
  • Sharif El-Leithy,
  • Jo Billings,
  • Idit Albert,
  • Jennifer Birch,
  • Mari Campbell,
  • Kim Ehntholt,
  • Lorna Fortune,
  • Nicola Gilbert,
  • Nick Grey,
  • Laurinne Hana,
  • Helen Kennerley,
  • Deborah Lee,
  • Sarah Lunn,
  • Dominic Murphy,
  • Mary Robertson,
  • Dorothy Wade,
  • Chris R. Brewin,
  • Michael A. P. Bloomfield

DOI
https://doi.org/10.1080/20008198.2021.1959707
Journal volume & issue
Vol. 13, no. 1

Abstract

Read online

Based on research from previous pandemics, studies of critical care survivors, and emerging COVID-19 data, we estimate that up to 30% of survivors of severe COVID will develop PTSD. PTSD is frequently undetected across primary and secondary care settings and the psychological needs of survivors may be overshadowed by a focus on physical recovery. Delayed PTSD diagnosis is associated with poor outcomes. There is a clear case for survivors of severe COVID to be systematically screened for PTSD, and those that develop PTSD should receive timely access to evidence-based treatment for PTSD and other mental health problems by multidisciplinary teams.

Keywords